Revolution Medicines Inc.

NASDAQ: RVMD · Real-Time Price · USD
36.30
0.28 (0.78%)
At close: Aug 15, 2025, 3:59 PM
36.32
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT

Revolution Medicines Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-247.79M -213.42M -194.57M -156.29M -133.23M -116M -161.54M -108.43M -98.3M -68.1M -56.51M -73.33M -61.22M -57.65M -52.68M -52.94M -44.3M -37.18M
Depreciation & Amortization
-20.74M 3.72M 3.39M 66K 2.8M 2.76M 2.86M 2.15M 1.77M 2.53M 2.6M 2.43M 2.33M 2.29M 2.06M 1.75M 1.84M 1.68M
Stock-Based Compensation
28.83M 25.08M 22.44M 20.77M 19.77M 16.21M 25.43M 13.67M 12.98M 9.7M 8.32M 8.14M 8.1M 6.64M 6.2M 5.83M 5.31M 3.39M
Other Working Capital
-10.71M 10.71M 12.66M 15.91M -660K -19.51M 8.79M -3.87M -1.43M -2.58M -12.36M 1.28M -3.76M -7.17M -3.41M 6.38M -2.14M -2.49M
Other Non-Cash Items
20.38M -12.26M -11.57M -8.1M -12.77M 33.13M -8.47M -1.28M -4.85M -3.58M -2.17M 10.66M 27K 667K 907K 997K 693K 534K
Deferred Income Tax
n/a n/a -762K n/a n/a n/a -43K -3.87M n/a n/a -419K n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-2.44M 2.44M 42.02M 13.13M -4.74M -47.21M 21.2M -2.73M 21.27M -2.95M -13.6M 12.18M -4.95M -7.11M 4.25M 7.78M 2.37M -5.67M
Operating Cash Flow
-221.76M -194.44M -138.29M -130.42M -128.17M -160.56M -120.56M -100.5M -67.12M -62.39M -61.79M -51.74M -55.72M -55.16M -39.27M -36.59M -34.08M -37.25M
Capital Expenditures
-7.45M -3.27M -1.22M -3.52M -2.4M -3.17M -2.32M -2.54M -1.12M -1.76M -2.88M -3.52M -2.53M -1.89M -1.18M -454K -1.31M -3.58M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 884.05M -79.89M 42.42M -5.75M 4.23M n/a -64.93M n/a n/a n/a n/a n/a
Purchase of Investments
-529.29M -510.04M -695.21M -364.88M -374.86M -701.68M -519.61M -170.04M -176.18M -193.1M -160.34M -212.96M -127.65M -111.82M -110.81M -168.25M -278.24M -114.04M
Sales Maturities Of Investments
571.02M 497.35M 303.53M 346.93M 485.2M 456.88M 141.52M 249.93M 133.75M 198.85M 156.11M 93.05M 192.58M 157.73M 120.53M 138.53M 156.76M 119.93M
Other Investing Acitivies
n/a n/a n/a n/a 110.34M -244.8M -884.05M 79.89M -42.42M 5.75M -4.23M -119.91M 64.93M 45.91M 9.72M -29.72M -121.47M 5.89M
Investing Cash Flow
34.28M -15.95M -392.9M -21.47M 107.94M -247.97M -380.4M 77.35M -43.54M 4M -7.1M -123.44M 62.4M 44.02M 8.53M -30.18M -122.78M 2.31M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
4.64M n/a 1.86M n/a 3.16M n/a 3.32M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
249.11M 874K 101.75M 3M 7.5M 810K 839.35M 1.01M 2.58M 499K 1.44M 209K 1.43M 305K 632K 319K 868K 555K
Financial Cash Flow
256.58M 874K 873.8M 77.29M 7.5M 810K 839.35M 1.01M 64.63M 324.2M 51.36M 248.34M 1.43M 305K 10.73M 319K 868K 282.26M
Net Cash Flow
69.1M -209.51M 342.61M -74.59M -12.72M -407.72M 337.75M -22.13M -46.03M 265.81M -17.53M 73.16M 8.11M -10.83M -20M -66.45M -156M 247.33M
Free Cash Flow
-229.21M -197.7M -139.51M -133.94M -130.57M -163.73M -122.88M -103.03M -68.24M -64.15M -64.66M -55.26M -58.24M -57.05M -40.45M -37.04M -35.39M -40.83M